Please wait a minute...
文章检索
预防医学  2019, Vol. 31 Issue (11): 1081-1085    DOI: 10.19485/j.cnki.issn2096-5087.2019.11.001
  论著 本期目录 | 过刊浏览 | 高级检索 |
1999—2018年浙江省新生儿遗传代谢病筛查情况分析
李强,周莹,徐艳华,毛华庆,徐益红
浙江大学医学院附属儿童医院,浙江 杭州 310052
Analysis on neonatal screening for inherited metabolic diseases in Zhejiang Province from 1999 to 2018
LI Qiang,ZHOU Ying,XU Yan-hua,MAO Hua-qing,XU Yi-hong
The Children's Hospital Affiliated to Medical College of Zhejiang University,Hangzhou, Zhejiang 310052,China
全文: PDF(565 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 评价1999—2018年浙江省新生儿遗传代谢病筛查工作质量,分析浙江省新生儿遗传代谢病流行情况,为制定出生缺陷防控政策提供依据。方法 通过浙江省新生儿疾病筛查中心新生儿疾病筛查数据库收集浙江省1999—2018年新生儿遗传代谢病筛查资料,分析先天性甲状腺功能减退症(CH),苯丙酮尿症/四氢生物蝶呤缺乏症(PKU/BH4D),先天性肾上腺皮质增生症(CAH),葡萄糖-6-磷酸脱氢酶缺乏症(G6PD)及其他氨基酸、脂肪酸、有机酸等代谢障碍疾病筛查率、患病率、可疑阳性患儿召回率、不合格血片补采率和血片迟递率等指标,评价浙江省新生儿疾病筛查质量和新生儿遗传代谢病流行情况。结果 1999—2018年浙江省共筛查新生儿10 016 839人,筛查率由1999年的6.46%上升至2018年的100.62%;阳性患儿召回率自2007年开始超过95%;血片不合格率控制在1%以下,2018年为0.06%;不合格血片补采率2004年开始超过99%;血片迟递率2018年下降至0.19%;采用串联质谱技术筛查的新生儿数占总筛查新生儿数的比例2018年达到92.75%。确诊新生儿遗传代谢病13 664例,其中CH 6 723例,PKU/BH4D 472例,CAH 125例,G6PD 5 644例,其他遗传代谢病700例,患病率分别为6.71/万、0.47/万、0.38/万、22.19/万和2.13/万。CH、PKU/BH4D、G6PD及其他遗传代谢病患病率分别以丽水市、杭州市、宁波市、衢州市最高,不同地区间差异均有统计学意义(P<0.05)。结论 浙江省新生儿遗传代谢病筛查率、阳性患儿召回率、不合格血片补采率及串联质谱技术筛查率较高,血片不合格率和迟递率稳定在较低水平;CH患病率高于全国水平,PKU/BH4D患病率低于全国水平。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
李强
周莹
徐艳华
毛华庆
徐益红
关键词 新生儿疾病筛查;遗传代谢病;出生缺陷;串联质谱技术    
AbstractObjective To evaluate the quality of neonatal screening work for inherited metabolic diseases,to learn the incidence of inherited metabolic diseases in newborns in Zhejiang Province from 1999 to 2018,and to provide scientific basis for formulating policies for control of birth defects. Methods The neonatal screening data for inherited metabolic diseases in Zhejiang Province from 1999 to 2018 were collected from the neonatal disease screening database of Zhejiang Neonatal Disease Screening Center,including congenital hypothyroidism(CH),phenylketonuria/tetrahydrobiopterin deficiency(PKU/BH4D),congenital adrenal hyperplasia(CAH),glucose-6-phosphate dehydrogenase deficiency(G6PD)and other metabolic disorders. The related indicators,such as the screening rate,prevalence rate,recall rate for suspected positive cases,resample rate of unqualified blood slides and rate of delayed blood slides delivery,were calculated to assess the quality of neonatal screening and understand the epidemic situation of inherited metabolic diseases in Zhejiang Province. Results A total of 10 016 839 newborns were screened and the rate rised from 6.46% in 1999 to 100.62% in 2018. The recall rate for suspected positive cases had exceeded 95% since 2007. The rate of unqualified blood tablets was under 1%(0.06% in 2018);the resample rate of unqualified blood slides had exceeded 99% since 2004;the rate of delayed blood slides delivery dropped to 0.19% in 2018. The proportion of newborns screened by tandem mass spectrometry reached 92.75% in 2018. There were 13 664 cases of inherited metabolic diseases confirmed,with 6 723 cases of CH(6.71/10 000),472 cases of PKU/BH4D(0.47/10 000),125 cases of CAH(0.38/10 000),5 644 cases of G6PD(22.19/10 000)and 700 cases of other metabolic disorders(2.13/10 000). The highest prevalence rate of CH,PKU/BH4D,G6PD and other metabolic disorders lay in Lishui,Hangzhou,Ningbo and Quzhou,respectively,which was significantly different in cities(P<0.05). Conclusion The neonatal screening rate for inherited metabolic diseases,recall rate for suspected positive cases and resample rate of unqualified blood slides are high,while the rate of unqualified blood slides and delayed blood slides delivery have been kept low in Zhejiang Province. The prevalence of CH is above and PKU/BH4D is below the national average.
Key wordsNeonatal screening    Inherited metabolic disease    Birth defects    Tandem mass spectrometry
          出版日期: 2019-11-01
中图分类号:  R722.11  
基金资助:国家重点研发计划(2018YFC1002700,2018YFC1002703)
通信作者: 李强,E-mail:liq@srrsh.com   
作者简介: 李强,本科,副主任医师,主要从事儿童保健工作
引用本文:   
李强,周莹,徐艳华,毛华庆,徐益红. 1999—2018年浙江省新生儿遗传代谢病筛查情况分析[J]. 预防医学, 2019, 31(11): 1081-1085.
LI Qiang,ZHOU Ying,XU Yan-hua,MAO Hua-qing,XU Yi-hong. Analysis on neonatal screening for inherited metabolic diseases in Zhejiang Province from 1999 to 2018. Preventive Medicine, 2019, 31(11): 1081-1085.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2019.11.001      或      http://www.zjyfyxzz.com/CN/Y2019/V31/I11/1081
[1] 赵正言,顾学范. 新生儿遗传代谢病筛查(第2版)[M]. 北京:人民卫生出版社,2015:10.
[2] 中华人民共和国卫生部.新生儿疾病筛查管理办法[Z/OL].[2019-09-06]. http://www.nwccw.gov.cn/2017-05/03/content_ 153282.htm.
[3] 赵正言. 新生儿遗传代谢病筛查进展[J]. 中国实用儿科杂志,2014,29(8):586-589.
[4] 浙江省卫生厅. 关于印发《浙江省新生儿疾病筛查实施方案》的通知[Z/OL].(2009-09-02)[2019-09-06]. http://www.zjuch.cn/Html/News/Articles/4199.html.
[5] 浙江省卫生厅. 关于印发《浙江省新生儿疾病筛查管理办法》(试行)[Z/OL].(2009-08-20)[2019-09-06]. http://www. zjuch.cn/html/news/articles/4193.html.
[6] 赖婷,李小洪,邓奎,等. 2006—2016年中国新生儿疾病筛查覆盖率分析[J]. 中国妇幼保健杂志,2018,33(16):3601- 3604.
[7] 国家卫生计生委临床检验中心新生儿遗传代谢病筛查实验室专家组. 新生儿遗传代谢病筛查质量指标共识[J]. 中华检验医学杂志,2017,40(5):352-355.
[8] LEHOTAY D C,HALL P,LEPAGE J,et al. LC MS/MS progress in newborn screening[J]. Clin Biochem,2011,44:21-31.
[9] 郑新灵. 81 086名新生儿的遗传代谢病筛查结果[J]. 浙江预防医学,2013,25(6):78,81.
[10]中华医学会儿科学分会内分泌遗传代谢组,中华预防医学会儿童保健分会新生儿疾病筛查学组. 先天性甲状腺功能减低症诊疗共识[J]. 中华儿科杂志,2011,49(6):421-424.
[11]中华医学会儿科学分会内分泌遗传代谢组,中华预防医学会儿童保健分会新生儿疾病筛查学组. 高苯丙氨酸血症的诊治共识[J]. 中华儿科杂志,2014,52(6):420-424.
[12]杨茹莱,童凡,徐艳华,等. 先天性甲状腺功能低下症2 789例诊断标准与治疗探讨及预后研究[J]. 中国儿童保健杂志,2017,25(11):1094-1097.
[13]AHRING K,BéLANGER-QUINTANA A,DOKOUPIL K. et al. Blood phenylalanine control in phenylketonuria:a survey of 10 European centres[J]. Eur J Clin Nutr,2011,65(2):275-278.
[14]强荣,余伍忠,蔡娜,等. 陕西地区苯丙酮尿症患儿苯丙氨酸羟化酶基因突变研究[J]. 中华医学遗传学杂志,2014,31(1):74-77.
[15]高伟华,张全斌,刘建平,等. 山西省经典型苯丙酮尿症患者苯丙氨酸羟化酶基因突变研究[J]. 中华医学遗传学杂志,2011,28(24):393-396.
[16]何江,王惠珍,徐发亮,等. 青海地区苯丙酮尿症患者苯丙氨酸羟化酶基因突变分析[J]. 中国当代儿科杂志,2015,17(11):1221-1227.
[17]国家卫生健康委临床检验中心新生儿疾病筛查室间质评专家委员会. 新生儿葡萄糖-6-磷酸脱氢酶缺乏症筛查与诊断实验室检测技术专家共识[J]. 中华检验医学杂志,2019,42(3):181-185.
[1] 徐艳华, 毛华庆, 徐益红, 杨茹莱. 浙江省新生儿疾病筛查工作质量监测与评价[J]. 预防医学, 2022, 34(8): 848-851.
[2] 吴璀璐, 杨建滨, 徐益红, 徐艳华, 杨茹莱, 毛华庆. 冷链定位系统在新生儿遗传代谢病筛查样本运输中的应用[J]. 预防医学, 2022, 34(8): 852-854,862.
[3] 杨茹莱, 沈亚平, 陈迟, 周莹, 徐艳华, 舒强. 2009—2021年浙江省新生儿遗传代谢病基因型分析[J]. 预防医学, 2022, 34(8): 760-764.
[4] 陈迟, 徐益红, 吴璀璐, 徐艳华, 毛华庆, 杨茹莱. 2009—2021年浙江省新生儿遗传代谢病串联质谱法筛查工作质量评价[J]. 预防医学, 2022, 34(8): 765-770.
[5] 郑新灵, 叶少燕, 祝莎莎, 许鹿舫, 罗丽丹, 季燕. 台州市新生儿葡萄糖-6-磷酸脱氢酶缺乏症筛查资料分析[J]. 预防医学, 2020, 32(2): 187-189.
[6] 刘丽迎, 康文娟, 董勤, 张晓刚, 阎亚琼. 53例苯丙酮尿症新生儿体格、智力和基因特征[J]. 预防医学, 2022, 34(9): 955-958.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed